CoChat

Resveratrol Inhibits Activation of Microglia after Stroke through Triggering Translocation of Smo to Primary Cilia

Open access
Liao, Hongyan, Huang, Jiagui, Liu, Jie, Chen, Yue, Zhu, Huimin, Li, Xuemei, Wen, Jun, Xiang, Qin, Yang, Qin · 2023 · Journal of Personalized Medicine

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Activated microglia act as a double-edged sword for stroke. In the acute phase of stroke, activated microglia might deteriorate neurological function. Therefore, it is of great clinical transforming potential to explore drugs or methods that can inhibit abnormal activation of microglia in the acute phase of stroke to improve neurological function after stroke. Resveratrol has a potential effect of regulating microglial activation and anti-inflammation. However, the molecular mechanism of resveratrol-inhibiting microglial activation has not been fully clarified. Smoothened (Smo) belongs to the Hedgehog (Hh) signaling pathway. Smo activation is the critical step that transmits the Hh signal across the primary cilia to the cytoplasm. Moreover, activated Smo can improve neurological function via regulating oxidative stress, inflammation, apoptosis, neurogenesis, oligodendrogenesis, axonal remodeling, and so on. More studies have indicated that resveratrol can activate Smo. However, it is currently unknown whether resveratrol inhibits microglial activation via Smo. Therefore, in this study, N9 microglia in vitro and mice in vivo were used to investigate whether resveratrol inhibited microglial activation after oxygen-glucose deprivation/reoxygenation (OGD/R) or middle cerebral artery occlusion/reperfusion (MCAO/R) injury and improved functional outcome via triggering translocation of Smo in primary cilia. We definitively found that microglia had primary cilia; resveratrol partially inhibited activation and inflammation of microglia, improved functional outcome after OGD/R and MCAO/R injury, and triggered translocation of Smo to primary cilia. On the contrary, Smo antagonist cyclopamine canceled the above effects of resveratrol. The study suggested that Smo receptor might be a therapeutic target of resveratrol for contributing to inhibit microglial activation in the acute phase of stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jpm13020268

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effects of resveratrol on infarct volume and neurological functional score after MCAO/R injury in vivo. (A,B) Quantification of infarction volumes with TTC staining at 24 h after MCAO/R injury in vivo. (C–E) Neurological function score with Longa score (C), Bederson score (D), and mNSS (E) were assayed at 3 d after MCAO/R injury in vivo. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl; (ANOVA, n = 6 each group).
Figure 1 Effects of resveratrol on infarct volume and neurological functional score after MCAO/R injury in vivo. (A,B) Quantification of infarction volumes with TTC staining at 24 h after MCAO/R injury in vivo. (C–E) Neurological function score with Longa score (C), Bederson score (D), and mNSS (E) were assayed at 3 d after MCAO/R injury in vivo. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl; (ANOVA, n = 6 each group).CC BY · PubMed Central
Figure 2 Resveratrol inhibited activation of microglia and inflammation after MCAO/R injury in vivo or OGD/R injury in vitro. (A) Analysis of immunofluorescent images showed activation of microglia in each group after MCAO/R injury. NC: Negative control, Iba1 antibody was replaced with PBS to serve as a negative control. Iba1, red; DAPI, blue. Scale bars = 50 μm. (B,C,G,H) Resveratrol downregulated expression of Iba1 protein in vivo or in vitro with western blotting assay. (D–F,I–K) ELISA was used to measure the levels of TNF-α, IL-1β, and IL-10 in brain homogenate and in the cell supernatant of microglia. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl. (ANOVA, B–F: n = 6 each group; G–K: n = 3 each group).
Figure 2 Resveratrol inhibited activation of microglia and inflammation after MCAO/R injury in vivo or OGD/R injury in vitro. (A) Analysis of immunofluorescent images showed activation of microglia in each group after MCAO/R injury. NC: Negative control, Iba1 antibody was replaced with PBS to serve as a negative control. Iba1, red; DAPI, blue. Scale bars = 50 μm. (B,C,G,H) Resveratrol downregulated expression of Iba1 protein in vivo or in vitro with western blotting assay. (D–F,I–K) ELISA was used to measure the levels of TNF-α, IL-1β, and IL-10 in brain homogenate and in the cell supernatant of microglia. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl. (ANOVA, B–F: n = 6 each group; G–K: n = 3 each group).CC BY · PubMed Central
Figure 3 Resveratrol triggered the translocation of Smo/Gli-1 molecules and the Shh signaling in microglia after OGD/R injury in vitro. (A) Resveratrol promoted Smo to translocate into primary cilia from cytoplasm in microglia after OGD/R injury in vitro. In the Nor or Ctrl group, Smo lay in cytoplasm. In the Res group, Smo translocated into the primary cilia. NC: Ac-tu and Smo antibodies were replaced with PBS. Primary cilia were labeled with Ac-tu, green; Smo, red; DAPI, blue. Scale bars = 10 μm. (B) Resveratrol promoted nuclear translocation of Gli-1 in microglia after OGD/R injury. In the Nor group, Gli-1 accumulated in cytoplasm. In the Ctrl group, Gli-1 partly transferred to the nucleus. In the Res group, Gli-1 almost transferred to the nucleus. NC: Gli-1 antibody was replaced with PBS to serve as a negative control. Gli-1, red; DAPI, blue. Scale bars = 50 μm. (C–G) Resveratrol-upregulated Shh, Ptc-1, Smo, and Gli-1 expression in microglia after OGD/R injury with Western blotting assay. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl. (ANOVA, n = 3 each group).
Figure 3 Resveratrol triggered the translocation of Smo/Gli-1 molecules and the Shh signaling in microglia after OGD/R injury in vitro. (A) Resveratrol promoted Smo to translocate into primary cilia from cytoplasm in microglia after OGD/R injury in vitro. In the Nor or Ctrl group, Smo lay in cytoplasm. In the Res group, Smo translocated into the primary cilia. NC: Ac-tu and Smo antibodies were replaced with PBS. Primary cilia were labeled with Ac-tu, green; Smo, red; DAPI, blue. Scale bars = 10 μm. (B) Resveratrol promoted nuclear translocation of Gli-1 in microglia after OGD/R injury. In the Nor group, Gli-1 accumulated in cytoplasm. In the Ctrl group, Gli-1 partly transferred to the nucleus. In the Res group, Gli-1 almost transferred to the nucleus. NC: Gli-1 antibody was replaced with PBS to serve as a negative control. Gli-1, red; DAPI, blue. Scale bars = 50 μm. (C–G) Resveratrol-upregulated Shh, Ptc-1, Smo, and Gli-1 expression in microglia after OGD/R injury with Western blotting assay. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl. (ANOVA, n = 3 each group).CC BY · PubMed Central
Figure 4 Cyclopamine deteriorated infarct volume, neurological functional score, microglia activation, and inflammation after stroke. (A,B) Quantification of infarction volumes with TTC staining at 24 h after MCAO/R injury in vivo. (C–E) Cyclopamine aggravated Longa score, Bederson score, and mNSS at 3 d after MCAO/R injury. (F) Analysis of immunofluorescent images showed activation of microglia in each group after MCAO/R injury. Scale bars = 50 μm. (G–P) The expression of Iba1 protein and Inflammatory factors in vivo or in vitro were measured by western blotting and ELISA. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl; ▲ p < 0.05 vs. Res; $ p < 0.05 vs. R+C (ANOVA, A–K: n = 6 each group; L–P: n = 3 each group).
Figure 4 Cyclopamine deteriorated infarct volume, neurological functional score, microglia activation, and inflammation after stroke. (A,B) Quantification of infarction volumes with TTC staining at 24 h after MCAO/R injury in vivo. (C–E) Cyclopamine aggravated Longa score, Bederson score, and mNSS at 3 d after MCAO/R injury. (F) Analysis of immunofluorescent images showed activation of microglia in each group after MCAO/R injury. Scale bars = 50 μm. (G–P) The expression of Iba1 protein and Inflammatory factors in vivo or in vitro were measured by western blotting and ELISA. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl; ▲ p < 0.05 vs. Res; $ p < 0.05 vs. R+C (ANOVA, A–K: n = 6 each group; L–P: n = 3 each group).CC BY · PubMed Central
Figure 5 Cyclopamine reversed the effect of resveratrol on translocation of Smo/Gli-1 molecules and the Shh signaling in microglia after OGD/R injury in vitro. (A) Cyclopamine reversed the effects of resveratrol promoting Smo to translocate into primary cilia from cytoplasm after OGD/R injury in vitro. In the Nor, Ctrl, R+C and Cyc groups, Smo lay in cytoplasm. In the Res group, Smo translocated into the primary cilia. Scale bars = 10 μm. (B) Cyclopamine reversed resveratrol-promoting nuclear translocation of Gli-1 in microglia after OGD/R injury. In the Nor group, Gli-1 accumulated in cytoplasm. In the Ctrl group, Gli-1 partly transferred to the nucleus. In the Res group, Gli-1 almost transferred to the nucleus. However, cyclopamine combined with resveratrol (R+C) or cyclopamine alone (Cyc) inhibited the nuclear translocation of Gli-1. Scale bars = 50 μm. (C–G) Cyclopamine downregulated the expression of Shh, Ptc-1, Smo, and Gli-1 in microglia after OGD/R injury with Western blotting assay. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl; ▲ p < 0.05 vs. Res; $ p < 0.05 vs. R+C (ANOVA, n = 3 each group).
Figure 5 Cyclopamine reversed the effect of resveratrol on translocation of Smo/Gli-1 molecules and the Shh signaling in microglia after OGD/R injury in vitro. (A) Cyclopamine reversed the effects of resveratrol promoting Smo to translocate into primary cilia from cytoplasm after OGD/R injury in vitro. In the Nor, Ctrl, R+C and Cyc groups, Smo lay in cytoplasm. In the Res group, Smo translocated into the primary cilia. Scale bars = 10 μm. (B) Cyclopamine reversed resveratrol-promoting nuclear translocation of Gli-1 in microglia after OGD/R injury. In the Nor group, Gli-1 accumulated in cytoplasm. In the Ctrl group, Gli-1 partly transferred to the nucleus. In the Res group, Gli-1 almost transferred to the nucleus. However, cyclopamine combined with resveratrol (R+C) or cyclopamine alone (Cyc) inhibited the nuclear translocation of Gli-1. Scale bars = 50 μm. (C–G) Cyclopamine downregulated the expression of Shh, Ptc-1, Smo, and Gli-1 in microglia after OGD/R injury with Western blotting assay. * p < 0.05 vs. Nor; # p < 0.05 vs. Ctrl; ▲ p < 0.05 vs. Res; $ p < 0.05 vs. R+C (ANOVA, n = 3 each group).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 19

Metadata

Authors
Liao, H., Huang, J., Liu, J., Chen, Y., Zhu, H., Li, X., Wen, J., Xiang, Q., & Yang, Q.
Affiliations
  • The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
  • Department of Neurology, Longevity District People’s Hospital of Chongqing, Chongqing 401220, China
Corresponding author
Yang, Qin
Venue
Journal of Personalized Medicine
Publisher
MDPI AG
Published
2023-01-31
Volume
13
Issue
2
Pages
268
ISSN
2075-4426 (ISSN-L)
OpenAlex
W4318777709
Cited by
19
References
55
Citations by year
2026: 7 · 2025: 6 · 2024: 6
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • Journal of Personalized Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81671309, 81971229, XZ2017ZR-ZY026, CYS17148)
  • Tibet Nature Science Foundation of Tibet (81671309, 81971229, XZ2017ZR-ZY026, CYS17148)
  • Postgraduate Research and Innovation Project of Chongqing (81671309, 81971229, XZ2017ZR-ZY026, CYS17148)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
resveratrol, microglial activation, stroke, Smoothened receptor, Hedgehog signaling, primary cilia, cyclopamine, oxygen-glucose deprivation/reoxygenation, middle cerebral artery occlusion/reperfusion, neuroinflammation, neuroprotection, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resveratrol Inhibits Activation of Microglia after Stroke through Triggering Translocation of Smo to Primary Cilia. https://app.cochat.ai/papers/10.3390/jpm13020268
The paper
Liao, H., Huang, J., Liu, J., Chen, Y., Zhu, H., Li, X., Wen, J., Xiang, Q., & Yang, Q. (2023). Resveratrol Inhibits Activation of Microglia after Stroke through Triggering Translocation of Smo to Primary Cilia. Journal of Personalized Medicine. https://doi.org/10.3390/jpm13020268

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.